Skip to content
GLP-1 Decoder

Victoza for Type 2 Diabetes: A1C Results, Weight

Yes. Victoza is FDA approved for type 2 diabetes: blood sugar goes down with this medicine for adults and children age 10 and older. It is for people with type 2 diabetes, used along with diet and exercise. In SCALE Obesity and Prediabetes, people on Saxenda lost 7.4% of body weight on average, vs 3% on placebo.

For type 2 diabetes
FDA approved
Active ingredient
liraglutide
How it is taken
daily injection
Best result (SCALE Obesity and Prediabetes)
7.4% weight loss

Victoza overview

How long it remains in your body
100%50%25%0%013 h26 h39 h2.2 d2.7 d50%25%12.5%time after the dose

Its half-life is about 13 hours. Only half remains at 13 h, while about 3% remains after five half-lives (2.7 d) in all.

Main trial weight loss
Victoza (LEAD-3)2.5 kgPlacebo1.1 kg

In LEAD-3, people with type 2 diabetes lost 2.5 kg over 52 weeks, compared with 1.1 kg on placebo.

Reference: FDA DailyMed label.

Who qualifies for it?

Victoza: who qualifies
SourceWho qualifies for it?
FDA labelBlood sugar goes down with this medicine for adults and children age 10 and older. It is for people with type 2 diabetes, used along with diet and exercise.
FDA labelThis medicine lowers the risk of death related to the heart, as well as heart attack and stroke. It is for adults with type 2 diabetes who also have heart disease.

Reference: FDA DailyMed label.

Trial results for type 2 diabetes

This group includes no Victoza trial. The trials test other brands that use the same ingredient.

Trials with the same ingredient (liraglutide)
TrialMedicineWho took partLengthPeopleMain resultComparison
SCALE Obesity and Prediabetes SaxendaAdults with obesity or overweight who do not have type 2 diabetes56 weeks3,7317.4% weight loss3% on placebo

Trial source: SCALE Obesity and Prediabetes (FDA label (DailyMed)).

What is different with type 2 diabetes?

Victoza label details for type 2 diabetes
What changesWhat the label says
HypoglycemiaLow blood sugar becomes more likely when you combine it with insulin or a sulfonylurea. Doses may need to be lowered.
Taken with insulin or sulfonylureasIf you take insulin or a sulfonylurea, including glipizide or glimepiride, together with it, low blood sugar is more likely. Your doctor may reduce those doses.

Taken from FDA labels: FDA DailyMed label.

Warnings from the FDA DailyMed label.

Coverage for type 2 diabetes

Medicare Part D can cover these medicines when they are prescribed for diabetes or cardiovascular disease.

Sources: humana.com.

Alternatives for type 2 diabetes

GLP-1 medicines and type 2 diabetes
MedicineFor type 2 diabetesHow it is takenTrial result
VictozaFDA approveddaily injectionNot listed
OzempicFDA approvedweekly injectionNot listed
RybelsusFDA approveddaily tabletNot listed
MounjaroFDA approvedweekly injectionA1C down 2.3 points
TrulicityFDA approvedweekly injectionA1C down 1.77 points
ByettaFDA approvedtwice-daily injectionNot listed
WegovyNot an approved useweekly injection or daily tablet9.6% weight loss
ZepboundNot an approved useweekly injection14.7% weight loss
FoundayoNot an approved usedaily tablet9.6% weight loss
SaxendaNot an approved usedaily injection7.4% weight loss

Sources cited: FDA label at DailyMed, PubMed.

Questions to ask your prescriber

See the full Victoza prescribing information on DailyMed.